| DNA demethylation and histone deacetylation inhibition co‐operate to re‐express estrogen receptor beta and induce apoptosis in prostate cancer cell‐lines TJ Walton, G Li, R Seth, SE McArdle, MC Bishop, RC Rees The Prostate 68 (2), 210-222, 2008 | 152 | 2008 |
| Immune landscape of breast cancers D Nagarajan, SEB McArdle Biomedicines 6 (1), 20, 2018 | 128 | 2018 |
| Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic … A Nasi, S McArdle, G Gaudernack, G Westman, C Melief, J Rockberg, ... Toxicology reports 7, 768-771, 2020 | 109 | 2020 |
| Cancer vaccines: Adjuvant potency, importance of age, lifestyle, and treatments S Cuzzubbo, S Mangsbo, D Nagarajan, K Habra, AG Pockley, ... Frontiers in immunology 11, 615240, 2021 | 85 | 2021 |
| ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring—even in hands of ELISPOT-inexperienced investigators W Zhang, R Caspell, AY Karulin, M Ahmad, N Haicheur, A Abdelsalam, ... Journal of immunotoxicology 6 (4), 227-234, 2009 | 80 | 2009 |
| A prototype methodology combining surface‐enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the … S Mian, G Ball, J Hornbuckle, F Holding, J Carmichael, I Ellis, S Ali, G Li, ... Proteomics 3 (9), 1725-1737, 2003 | 74 | 2003 |
| Immune escape in glioblastoma multiforme and the adaptation of immunotherapies for treatment JRD Pearson, S Cuzzubbo, S McArthur, LG Durrant, J Adhikaree, ... Frontiers in Immunology 11, 582106, 2020 | 67 | 2020 |
| Anti-tumour therapeutic efficacy of OX40L in murine tumour model SA Ali, M Ahmad, J Lynam, CS McLean, C Entwisle, P Loudon, E Choolun, ... Vaccine 22 (27-28), 3585-3594, 2004 | 67 | 2004 |
| Assessing the toxic effects of DMSO on cord blood to determine exposure time limits and the optimum concentration for cryopreservation LJ Fry, S Querol, SG Gomez, S McArdle, R Rees, JA Madrigal Vox sanguinis 109 (2), 181-190, 2015 | 65 | 2015 |
| Immune-phenotyping and transcriptomic profiling of peripheral blood mononuclear cells from patients with breast cancer: identification of a 3 gene signature which predicts … GA Foulds, J Vadakekolathu, TMA Abdel-Fatah, D Nagarajan, S Reeder, ... Frontiers in immunology 9, 2028, 2018 | 57 | 2018 |
| Estimation of peptide concentration by a modified bicinchoninic acid assay KN Kapoor, DT Barry, RC Rees, IA Dodi, SEB McArdle, CS Creaser, ... Analytical Biochemistry 393 (1), 138-140, 2009 | 54 | 2009 |
| HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers MG Mathieu, AJ Linley, SP Reeder, C Badoual, E Tartour, RC Rees, ... Cancer immunity 10 (1), 2, 2010 | 53 | 2010 |
| The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo AJ Linley, MG Mathieu, AK Miles, RC Rees, SEB McArdle, T Regad Journal of Biological Chemistry 287 (17), 13633-13643, 2012 | 50 | 2012 |
| The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines DP Assudani, RBV Horton, MG Mathieu, SEB McArdle, RC Rees Cancer Immunology, Immunotherapy 56, 70-80, 2007 | 47 | 2007 |
| Avoiding room temperature storage and delayed cryopreservation provide better postthaw potency in hematopoietic progenitor cell grafts LJ Fry, SQ Giner, SG Gomez, M Green, S Anderson, J Horder, S McArdle, ... Transfusion 53 (8), 1834-1842, 2013 | 46 | 2013 |
| Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer VM Phatak, SM Croft, SG Rameshaiah Setty, A Scarpellini, DC Hughes, ... Amino Acids 44, 33-44, 2013 | 44 | 2013 |
| Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony … SA Ali, J Lynam, CS McLean, C Entwisle, P Loudon, JM Rojas, ... The Journal of Immunology 168 (7), 3512-3519, 2002 | 40 | 2002 |
| Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant SEB McArdle, RC Rees, KA Mulcahy, J Saba, CA McIntyre, AK Murray Cancer Immunology, Immunotherapy 49, 417-425, 2000 | 40 | 2000 |
| Novel prostate acid phosphatase‐based peptide vaccination strategy induces antigen‐specific T‐cell responses and limits tumour growth in mice JMS Saif, J Vadakekolathu, SS Rane, D McDonald, M Ahmad, M Mathieu, ... European journal of immunology 44 (4), 994-1004, 2014 | 38 | 2014 |
| HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer TMA Abdel-Fatah, SEB McArdle, C Johnson, PM Moseley, GR Ball, ... British journal of cancer 110 (10), 2450-2461, 2014 | 36 | 2014 |
